Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: Optimization studies

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 5833-5845

  Fernandes, Julio C ^a   Qiu, Xingping ^b   Winnik, Francoise M ^b   Benderdour, Mohamed ^a   Zhang, Xiaoling ^c   Dai, Kerong ^c   Shi, Qin ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chitosan; Folate targeted; Gene delivery; Nonviral vector; SiRNA

Indexed keywords

CHITOSAN; FOLIC ACID; NANOPARTICLE; SMALL INTERFERING RNA; NANOCAPSULE;

ANALYTICAL PARAMETERS; ARTICLE; CONTROLLED STUDY; GENE DELIVERY SYSTEM; GENE SILENCING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROCESS OPTIMIZATION; RNA SEQUENCE; CHEMISTRY; EXPERIMENTAL NEOPLASM; GENETICS; HELA CELL; METHODOLOGY; TUMOR CELL LINE; ULTRASTRUCTURE;

CELL LINE, TUMOR; CHITOSAN; FOLIC ACID; GENE SILENCING; HELA CELLS; HUMANS; MOLECULAR WEIGHT; NANOCAPSULES; NEOPLASMS, EXPERIMENTAL; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84875819123     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S35567     Document Type: Article

References (26)

1. Gary DJ, Puri N, Won YY. Polymer-based siRNA delivery: Perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J Control Release. 2007;121:64-73.
2. Zhang S, Zhao B, Jiang H, Wang B, Ma B. Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release. 2007;123:1-10.
3. De Fougerrolles AR. Delivery vehicles for small interfering RNA in vivo. Hum Gene Ther. 2008;19:125-132.
4. Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature. 2000;404:293-296.
5. Chen M, Granger AJ, Vanbrocklin MW, et al. Inhibition of avian leukosis virus replication by vector-based RNA interference. Virology. 2007;365:464-472.
6. Liu X, Howard KA, Dong M, et al. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials. 2007;28:1280-1288.
7. Rojanarata T, Opanasopit P, Techaarpornkul S, Ngawhirunpat T, Ruktanonchai U. Chitosan-thiamine pyrophosphate as a novel carrier for siRNA delivery. Pharm Res. 2008;25:2807-2814.
8. Katas H, Alpar HO. Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release. 2006;115: 216-225.
9. Katas H, Chen S, Osamuyimen AA, Cevher E, Alpar HO. Effect of preparative variables on small interfering RNA loaded poly(D, L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method. J Microencapsul. 2008;25:541-548.
10. Howard KA, Rahbek UL, Liu X, et al. RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol Ther. 2006;14:476-484.
11. Godbey WT, Wu KK, Mikos AG. Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res A. 1999;45:268-275.
12. Lavertu M, Methot S, Tran-Khanh N, Buschmann MD. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials. 2006;27:4815-4824.
13. Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev. 2000;41:147-162.
14. Low PS, Antony AC. Folate receptor-targeted drugs for cancer and inflammatory diseases. Adv Drug Deliv Rev. 2004;56:1055-1058.
15. Lee D, Lockey R, Mohapatra S. Folate receptor-mediated cancer cell specific gene delivery using folic acid-conjugated oligochitosans. J Nanosci Nanotechnol. 2006;6:2860-2866.
16. Allan GG, Peyron M. Molecular weight manipulation of chitosan II: prediction and control of extent of depolymerization by nitrous acid. Carbohydr Res. 1995;277:273-282.
17. Mima S, Miya M, Iwamoto R, Yoshikawa S. Highly deacetylated chitosan and its properties. J Appl Polym Sci. 1983;28:1909-1917.
18. Cho KC, Jeong JH, Chung HJ, Joe CO, Kim SW, Park TG. Folate receptor-mediated intracellular delivery of recombinant caspase-3 for inducing apoptosis. J Control Release. 2005;108:121-131.
19. Bolstad AI, Eiken HG, Rosenlund B, Alarcón-Riquelme ME, Jonsson R. Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary Sjögren's syndrome. Arthritis Rheum. 2003;48:174-185.
20. Kreuzer KA, Lass U, Landt O, et al. Highly sensitive and specific fluorescence reverse transcription-PCR assay for the pseudogene-free detection of beta-actin transcripts as quantitative reference. Clin Chem. 1999;45:297-300.
21. Chan P, Kurisawa M, Chung JE, Yang YY. Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery. Biomaterials. 2007;28:540-549.
22. Mansouri S, Cuie Y, Winnik F, et al. Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials. 2006;27:2060-2065.
23. Kim SH, Jeong JH, Cho KC, Kim SW, Park TG. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). J Control Release. 2005;104:223-232.
24. Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem Rev. 2009;109:259-302.
25. Nakashima-Matsushita N, Homma T, Yu S, et al. Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheum. 1999;42:1609-1616.
26. Fernandes JC, Wang H, Jreyssaty C, et al. Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis. Mol Ther. 2008;16:1243-1251.